BEVYXXA (Portola Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the BEVYXXA drug offered from Portola Pharmaceuticals, Inc.. This Factor Xa Inhibitors [MoA],Factor Xa Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Portola Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | betrixaban |
SUBSTANCE NAME: | BETRIXABAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Factor Xa Inhibitors [MoA],Factor Xa Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, GELATIN COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-07-07 |
END MARKETING DATE: | 0000-00-00 |
BEVYXXA HUMAN PRESCRIPTION DRUG Details:
Item Description | BEVYXXA from Portola Pharmaceuticals, Inc. |
LABELER NAME: | Portola Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 80(mg/1) |
START MARKETING DATE: | 2017-07-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69853-0201_5e825dd0-d74c-4826-9235-a3bf5d07db42 |
PRODUCT NDC: | 69853-0201 |
APPLICATION NUMBER: | NDA208383 |
Other BETRIXABAN Pharmaceutical Manufacturers / Labelers: